Differential immunological aberrations in patients with primary and secondary sjogren's syndrome

Scandinavian Journal of Immunology

Volumn 45, Issue 6, 1997, Pages 698-705

  Kroneld, U ^a,c   Halse, A K ^b   Jonsson, R ^b   Bremell, T ^a   Tarkowski, A ^a   Carlsten, H ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF BERGEN   (Norway)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 4; INTERLEUKIN 6; POKEWEED MITOGEN;

ADULT; ARTICLE; B LYMPHOCYTE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; PHENOTYPE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SALIVARY GLAND; SJOEGREN SYNDROME; T LYMPHOCYTE;

EID: 0030963886     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1997.d01-449.x     Document Type: Article

References (27)

1. Isaacson P, Spencer J. Autoimmunity and malignancy. In: Autoimmune diseases: focus on Sjögren's syndrome. Oxford, UK, BIOS Scientific Publishers Limited, 1994:189-204.
2. Mann DL. Immunogenetics of Sjögren's syndrome. In: Talal N, Moutsopoulos HM, Kassan SS, eds. Sjögren's syndrome. Clinical and Immunological Aspects. Springer-Verlag, Berlin, 1987:235-43.
3. Moutsopoulos HM, Fauci A. Immunoregulation in Sjögren's syndrome. Influence of serum factors on T-cell subpopulations. J Clin Invest 1980;65:519-28.
4. Morimoto C, Reinherz EL, Nadler LM, Distaso JA, Steinberg AD, Schlossman SF. Comparison in T- and B-cell markers in patients with Sjögren's syndrome and systemic lupus erythematosus. Clin Immunol Immunopathol 1982;22:270-7.
5. Bakhshi A, Miyasaka N, Kavathas P et al. Lymphocyte subsets in Sjögren's syndrome: a quantitative analysis using monoclonal antibodies and the fluorescence-activated cell sorter. J Clin Lab Immunol 1983;10:63-9.
6. Leventhal BG, Waldorf DS, Talal N. Impaired lymphocyte transformation and delayed hypersensitivity in Sjögren's syndrome. J Clin Invest 1967;46:1338-45.
7. Fox RI, ed. Sjögren's syndrome. Rheumatic Disease Clinics of North America. Philadelphia: WB Saunders Company, 1992.
8. Price EJ, Venables PJW. The etiopathogenesis of Sjögren's syndrome. Seminars in Arthritis and Rheumatism 1995;25:117-33.
9. Fox RI, Robinson CA, Curd JG, Kozin F, Howell FW. Sjögren's syndrome: proposed criteria for classification. Arthritis Rheum 1986;29:577-85.
10. Manthorpe R, Oxholm P, Prause JU, Schiödt M. The Copenhagen criteria for Sjögren's syndrome. Scand J Rheumatol 1986;suppl. 61:19-21.
11. Krasse B, Gustafsson B. Buffer effect of saliva stimulated and at meals. Am Dent Assoc 1958;56:50-4.
12. Ericson T. Secretion of salivary glycoproteins. In: Emmelin N, Zotterman Y, eds. Oral physiology. Oxford: Pergamon Press, 1972:75-81.
13. Daniels TE. Labial salivary gland biopsy in Sjögren's syndrome. Arthritis Rheum 1984;27:147-56.
14. Greenspan JS, Daniels TE, Talal N, Sylvester RA. The histopathology of Sjögren's syndrome in labial salivary gland biopsies. Oral Surg, Oral Med & Oral Pathol 1974;37:217-29.
15. Czerkinsky C, Nilsson L-Å, Nygren H, Ouchterlony Ö, Tarkowski A. A solid-phase enzyme linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J Immunol Methods 1983;65:109-21.
16. Tarkowski A, Bjursten LM, Nilsson L-Å, Nygren H. False positive results in class-specific rheumatoid factor (RF) assays due to interaction between RF and Fc fragments of anti-immunoglobulin indicator reagents. J Immunol Methods 1983;58:171-82.
17. Tarkowski E, Rosengren L, Blomstrand C et al. Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke 1995;26:1393-8.
18. Czerkinsky C, Andersson G, Ekre H-P, Nilsson L-Å, Klareskog L, Oucherlony Ö. Reverse ELISPOT assay for clonal analysis of cytokine production. I. Enumeration of gamma-interferon-secreting cells. J Immunol Methods 1988;110:29-36.
19. Tarkowski E, Naver H, Wallin G, Blomstrand C, Tarkowski A. Lateralization of T-lymphocyte responses in patients with stroke. Effect of sympathetic dysfunction? Stroke 1995;26:57-62.
20. Ichikawa Y, Shimizu H, Yoshida M, Takaya M, Arimori S. Accessory molecules expressed on the peripheral blood or synovial fluid T lymphocytes from patients with Sjögren's syndrome or rheumatoid arthritis. Clin Exp Immunol 1992;10:447-54.
21. Fox RI, Carstens SA, Fong S, Robinson CA, Howell F, Vaughan JH. Use of monoclonal antibodies to analyze peripheral blood and salivary gland lymphocyte subsets in Sjögren's syndrome. Arthritis Rheum 1982;25:419-26.
22. Lindahl G, Hedfors E, Klareskog L, Forsum U. Epithelial HLA-DR expression and T lymphocyte subsets in salivary glands in Sjögren's syndrome. Clin Exp Immunol 1985;61:475-82.
23. Ichikawa Y, Shimizu H, Yoshida M, Arimori S. Activation of T cell subsets in the peripheral blood of patients with Sjögren's syndrome. Multicolor flow cutometric analysis. Arthritis Rheum 1990;33:1674-81.
24. Ichikawa Y, Shimizu H, Takahashi K et al. Lymphocyte subsets of the peripheral blood in Sjögren's syndrome and rheumatoid arthritis. Clin Exp Immunol 1989;7:55-61.
25. Steinberg AD, Klinman DM. Pathogenesis of systemic lupus erythematosus. In: Klippel JH, ed. Systemic Lupus Erythematosus. Rheumatic Disease Clinics of North America. Philadelphia: WB Saunders Company 1988;14:25-42.
26. Fox RI, Kang H-I. Pathogenesis of Sjögren's syndrome. In: Rheumatic Disease Clinics of North America. Philadelphia: WB Saunders Company 1992;18:517-38.
27. Harley JB, Alexander EL, Bias WB et al. Anti-Ro (SS-A) and anti-La (SS-B) in patients with Sjögren's syndrome. Arthritis Rheum 1986;29:196-206.